RXO (RXO) Is Up 7.2% After Strong Brokerage Growth Narrows Losses - Has The Bull Case Changed?

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

  • In the past quarter, RXO, Inc. reported second-quarter 2026 results showing sales of US$1,774 million versus US$1,419 million a year earlier, with a net loss of US$9 million and basic and diluted loss per share from continuing operations unchanged at US$0.05.
  • Despite a wider six-month net loss of US$45 million versus US$40 million a year earlier, RXO’s brokerage revenue growth and better-than-expected performance in brokerage and last-mile operations pointed to improving operating momentum and supported management’s outlook for higher adjusted EBITDA in the third quarter.
  • With RXO’s brokerage revenue rising strongly year over year, we’ll now examine how this earnings momentum affects the company’s broader investment narrative.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

RXO Investment Narrative Recap

To own RXO, you need to believe its asset light brokerage model can turn growing volumes into sustainable profits while managing freight and sector cyclicality. The latest quarter’s strong brokerage revenue and improved EBITDA outlook support the near term catalyst of execution in brokerage and last mile, while the biggest risk remains exposure to soft freight demand and pressured margins. This earnings beat does not remove that risk, but it does suggest the short term trajectory has not materially worsened.

One announcement that frames this quarter well is RXO’s February 2026 refinancing, where it issued US$400 million of 6.375% senior notes due 2031 and redeemed higher coupon 7.500% notes due 2027. Together with the new US$450 million ABL facility, this move refreshed RXO’s capital structure at a lower interest cost, which can matter for the catalyst of improving EBITDA and cash generation if operating trends continue to stabilize.

Yet, against this improving EBITDA outlook, investors should be aware that RXO still faces concentrated exposure to freight softness and...

RXO's narrative projects $7.4 billion revenue and $119.4 million earnings by 2029. This requires 8.6% yearly revenue growth and a $224.4 million earnings increase from -$105.0 million today.

Uncover how RXO's forecasts yield a $21.53 fair value, in line with its current price.

Exploring Other Perspectives

RXO 1-Year Stock Price Chart
RXO 1-Year Stock Price Chart

Some of the lowest ranked analysts were already assuming only about 7.7% annual revenue growth and earnings of roughly US$53.2 million by 2029, so this brokerage upside may or may not shift that more cautious view.

Explore 4 other fair value estimates on RXO - why the stock might be worth as much as 48% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your RXO research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free RXO research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate RXO's overall financial health at a glance.

Ready For A Different Approach?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

  • Find 52 companies with promising cash flow potential yet trading below their fair value.
  • Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
  • We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.